Atorvastatin-fig-1 (Atorvastatin Fig 1)
Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71335-2241
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71335-2241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Atorvastatin-fig-2 (Atorvastatin Fig 2)
This text appears to be a part of a statistical analysis or study report. It includes information about cumulative hazard percentages, the use of placebo and atorvastatin, a hazard ratio of 0.63, and the time to the first primary endpoint over a four-year follow-up period. However, without additional context or clearer text, it is difficult to provide a more specific description.*
Atorvastatin-fig-3 (Atorvastatin Fig 3)
The text provided is a table showing the percentage of subjects experiencing an event in relation to different doses of Atorvastatin. The table also includes a hazard ratio (HR) and its statistical significance (P-value) for the comparison between Atorvastatin 80 mg and an unspecified reference group. The table also displays a graph with a time axis representing the years until the first major cardiovascular endpoint.*
Atorvastatin-st (Atorvastatin St)
Label (Lbl713352241)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
